These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16855632)

  • 1. Aberrant stabilization of c-Myc protein in some lymphoblastic leukemias.
    Malempati S; Tibbitts D; Cunningham M; Akkari Y; Olson S; Fan G; Sears RC
    Leukemia; 2006 Sep; 20(9):1572-81. PubMed ID: 16855632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen.
    Bubman D; Guasparri I; Cesarman E
    Oncogene; 2007 Jul; 26(34):4979-86. PubMed ID: 17310999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Kaposi's sarcoma-associated herpesvirus LANA protein stabilizes and activates c-Myc.
    Liu J; Martin HJ; Liao G; Hayward SD
    J Virol; 2007 Oct; 81(19):10451-9. PubMed ID: 17634226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability.
    Sears R; Nuckolls F; Haura E; Taya Y; Tamai K; Nevins JR
    Genes Dev; 2000 Oct; 14(19):2501-14. PubMed ID: 11018017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
    Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
    Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of NBS1 contributes to transformation through the activation of phosphatidylinositol 3-kinase/Akt.
    Chen YC; Su YN; Chou PC; Chiang WC; Chang MC; Wang LS; Teng SC; Wu KJ
    J Biol Chem; 2005 Sep; 280(37):32505-11. PubMed ID: 16036916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IRS1/β-Catenin Axis Is Activated and Induces MYC Expression in Acute Lymphoblastic Leukemia Cells.
    Fernandes JC; Rodrigues Alves APN; Machado-Neto JA; Scopim-Ribeiro R; Fenerich BA; da Silva FB; Simões BP; Rego EM; Traina F
    J Cell Biochem; 2017 Jul; 118(7):1774-1781. PubMed ID: 27987331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Axin1 scaffold protein promotes formation of a degradation complex for c-Myc.
    Arnold HK; Zhang X; Daniel CJ; Tibbitts D; Escamilla-Powers J; Farrell A; Tokarz S; Morgan C; Sears RC
    EMBO J; 2009 Mar; 28(5):500-12. PubMed ID: 19131971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triggering Fbw7-mediated proteasomal degradation of c-Myc by oridonin induces cell growth inhibition and apoptosis.
    Huang HL; Weng HY; Wang LQ; Yu CH; Huang QJ; Zhao PP; Wen JZ; Zhou H; Qu LH
    Mol Cancer Ther; 2012 May; 11(5):1155-65. PubMed ID: 22389469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of MCL1, c-myc, and cyclin D2 protein degradation in ponatinib-induced cytotoxicity against T315I(+) Ph+leukemia cells.
    Inoue C; Sobue S; Kawamoto Y; Nishizawa Y; Ichihara M; Abe A; Hayakawa F; Suzuki M; Nozawa Y; Murate T
    Biochem Biophys Res Commun; 2020 May; 525(4):1074-1080. PubMed ID: 32184020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-dependent protein kinase catalytic subunit modulates the stability of c-Myc oncoprotein.
    An J; Yang DY; Xu QZ; Zhang SM; Huo YY; Shang ZF; Wang Y; Wu DC; Zhou PK
    Mol Cancer; 2008 Apr; 7():32. PubMed ID: 18426604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of c-myc degradation by nickel compounds and hypoxia.
    Li Q; Kluz T; Sun H; Costa M
    PLoS One; 2009 Dec; 4(12):e8531. PubMed ID: 20046830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells.
    Gregory MA; Hann SR
    Mol Cell Biol; 2000 Apr; 20(7):2423-35. PubMed ID: 10713166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting lactate dehydrogenase A (LDHA) exerts antileukemic effects on T-cell acute lymphoblastic leukemia.
    Yu H; Yin Y; Yi Y; Cheng Z; Kuang W; Li R; Zhong H; Cui Y; Yuan L; Gong F; Wang Z; Li H; Peng H; Zhang G
    Cancer Commun (Lond); 2020 Oct; 40(10):501-517. PubMed ID: 32820611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase A regulates MYC protein through transcriptional and post-translational mechanisms in a catalytic subunit isoform-specific manner.
    Padmanabhan A; Li X; Bieberich CJ
    J Biol Chem; 2013 May; 288(20):14158-14169. PubMed ID: 23504319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The B cell antigen receptor activates the Akt (protein kinase B)/glycogen synthase kinase-3 signaling pathway via phosphatidylinositol 3-kinase.
    Gold MR; Scheid MP; Santos L; Dang-Lawson M; Roth RA; Matsuuchi L; Duronio V; Krebs DL
    J Immunol; 1999 Aug; 163(4):1894-905. PubMed ID: 10438924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drosophila insulin and target of rapamycin (TOR) pathways regulate GSK3 beta activity to control Myc stability and determine Myc expression in vivo.
    Parisi F; Riccardo S; Daniel M; Saqcena M; Kundu N; Pession A; Grifoni D; Stocker H; Tabak E; Bellosta P
    BMC Biol; 2011 Sep; 9():65. PubMed ID: 21951762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fbw7 promotes ubiquitin-dependent degradation of c-Myb: involvement of GSK3-mediated phosphorylation of Thr-572 in mouse c-Myb.
    Kitagawa K; Hiramatsu Y; Uchida C; Isobe T; Hattori T; Oda T; Shibata K; Nakamura S; Kikuchi A; Kitagawa M
    Oncogene; 2009 Jun; 28(25):2393-405. PubMed ID: 19421138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation.
    Welcker M; Orian A; Jin J; Grim JE; Harper JW; Eisenman RN; Clurman BE
    Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9085-90. PubMed ID: 15150404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: alternative glycosylation/phosphorylation of THR-58, a known mutational hot spot of c-Myc in lymphomas, is regulated by mitogens.
    Kamemura K; Hayes BK; Comer FI; Hart GW
    J Biol Chem; 2002 May; 277(21):19229-35. PubMed ID: 11904304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.